PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares

Core Viewpoint - Psyence Group Inc. is conducting a non-brokered private placement to raise up to C$600,000 through the issuance of 6,000,000 common shares at C$0.10 each, aimed at pursuing strategic transactions and general operational needs [1][2]. Group 1 - The offering is expected to close around June 25, 2025, pending necessary regulatory approvals [3]. - The net proceeds will be utilized for evaluating potential acquisitions and business combinations, as well as for general administrative expenses and maintaining listing status [2][4]. - The securities issued will be subject to a statutory hold period of four months and one day, with potential extensions if a significant transaction occurs [4]. Group 2 - Psyence Group focuses on developing nature-derived psilocybin products for mental health treatment, particularly in palliative care contexts [5][6]. - The company emphasizes its commitment to evidence-based research in the production of psychedelic medicines [5].